Klaas Hoekman

6.4k total citations
102 papers, 5.2k citations indexed

About

Klaas Hoekman is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Klaas Hoekman has authored 102 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 32 papers in Cancer Research and 29 papers in Molecular Biology. Recurrent topics in Klaas Hoekman's work include Angiogenesis and VEGF in Cancer (18 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Klaas Hoekman is often cited by papers focused on Angiogenesis and VEGF in Cancer (18 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Klaas Hoekman collaborates with scholars based in Netherlands, United Kingdom and United States. Klaas Hoekman's co-authors include Herbert M. Pinedo, Henk M.W. Verheul, Giuseppe Giaccone, Henk J. Broxterman, Hester van Cruijsen, Tjeerd J. Postma, O. L. M. Bijvoet, J.J. Heimans, Socrates E. Papapoulos and C.C.P. Verstappen and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Klaas Hoekman

101 papers receiving 5.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Klaas Hoekman 2.4k 1.9k 999 983 478 102 5.2k
Giannoula Klement 1.7k 0.7× 2.3k 1.2× 666 0.7× 1.2k 1.2× 847 1.8× 67 4.9k
Marek Z. Wojtukiewicz 2.2k 0.9× 1.0k 0.5× 809 0.8× 939 1.0× 996 2.1× 190 4.5k
K. Havemann 1.8k 0.8× 1.9k 1.0× 1.1k 1.1× 716 0.7× 702 1.5× 267 5.2k
Vincent A. Memoli 1.6k 0.7× 1.9k 1.0× 960 1.0× 1.5k 1.6× 371 0.8× 124 4.8k
Bridget A. Robinson 2.0k 0.8× 1.3k 0.7× 697 0.7× 711 0.7× 281 0.6× 140 4.4k
Cornelis F.M. Sier 2.1k 0.9× 1.9k 1.0× 678 0.7× 2.0k 2.0× 560 1.2× 130 5.4k
Siow Ming Lee 2.4k 1.0× 1.6k 0.8× 2.0k 2.0× 547 0.6× 182 0.4× 171 4.9k
Catherine Butterfield 1.4k 0.6× 3.8k 2.0× 731 0.7× 1.8k 1.8× 521 1.1× 33 6.5k
Steven J. Harper 1.2k 0.5× 4.6k 2.3× 753 0.8× 1.0k 1.0× 306 0.6× 143 8.3k
Jacintha O’Sullivan 1.7k 0.7× 2.2k 1.1× 697 0.7× 1.2k 1.2× 226 0.5× 171 5.3k

Countries citing papers authored by Klaas Hoekman

Since Specialization
Citations

This map shows the geographic impact of Klaas Hoekman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaas Hoekman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaas Hoekman more than expected).

Fields of papers citing papers by Klaas Hoekman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaas Hoekman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaas Hoekman. The network helps show where Klaas Hoekman may publish in the future.

Co-authorship network of co-authors of Klaas Hoekman

This figure shows the co-authorship network connecting the top 25 collaborators of Klaas Hoekman. A scholar is included among the top collaborators of Klaas Hoekman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaas Hoekman. Klaas Hoekman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baselga, José, Andrés Cervantes, Erika Martinelli, et al.. (2010). Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors. Clinical Cancer Research. 16(19). 4876–4883. 95 indexed citations
2.
Veldt, Astrid A.M. van der, Richard R. de Haas, John B.A.G. Haanen, et al.. (2009). Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib. Angiogenesis. 12(1). 69–79. 47 indexed citations
3.
Cruijsen, Hester van, Astrid A.M. van der Veldt, Dinja Oosterhoff, et al.. (2008). Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival. Clinical Cancer Research. 14(18). 5884–5892. 111 indexed citations
4.
Piersma, Sander R., Henk J. Broxterman, Richard R. de Haas, et al.. (2008). Proteomics of the TRAP-induced platelet releasate. Journal of Proteomics. 72(1). 91–109. 93 indexed citations
5.
Jiménez, Connie R., Jaco C. Knol, Klaas Hoekman, et al.. (2007). Automated serum peptide profiling using novel magnetic C18 beads off‐line coupled to MALDI‐TOF‐MS. PROTEOMICS - CLINICAL APPLICATIONS. 1(6). 598–604. 29 indexed citations
6.
Jellema, Anke Petra, Ben J. Slotman, Martín Müller, et al.. (2006). Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly. Cancer. 107(3). 544–553. 36 indexed citations
7.
Hinsbergh, Victor W.M. van, Pieter Koolwijk, & Klaas Hoekman. (2005). The hemostatic system in angiogenesis. Birkhäuser Basel eBooks. 247–266. 1 indexed citations
8.
Cruijsen, Hester van, Giuseppe Giaccone, & Klaas Hoekman. (2005). Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. International Journal of Cancer. 117(6). 883–888. 158 indexed citations
9.
Hensbergen, Yvette van, Henk J. Broxterman, Sareena Rana, et al.. (2004). Reduced Growth, Increased Vascular Area, and Reduced Response to Cisplatin in CD13-Overexpressing Human Ovarian Cancer Xenografts. Clinical Cancer Research. 10(3). 1180–1191. 44 indexed citations
10.
Bruin, Michiel de, Kasper van der Born, Frank A.E. Kruyt, et al.. (2003). Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity. British Journal of Cancer. 88(6). 957–964. 62 indexed citations
11.
Hensbergen, Yvette van, Henk J. Broxterman, Yvonne W. Elderkamp, et al.. (2002). A doxorubicin–CNGRC-peptide conjugate with prodrug properties. Biochemical Pharmacology. 63(5). 897–908. 70 indexed citations
12.
Brande, Jan Van den, Vinodh R. Nannan Panday, Klaas Hoekman, et al.. (2001). Pharmacologic Study of Paclitaxel Administered With or Without the Cytoprotective Agent Amifostine, and Given as a Single Agent or in Combination With Epirubicin and Cisplatin in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology. 24(4). 401–403. 3 indexed citations
13.
Postma, Tjeerd J., Klaas Hoekman, J.M.G.H. van Riel, J.J. Heimans, & Jan B. Vermorken. (1999). Peripheral Neuropathy Due to Biweekly Paclitaxel, Epirubicin and Cisplatin in Patients with Advanced Ovarian Cancer. Journal of Neuro-Oncology. 45(3). 241–246. 23 indexed citations
14.
Hoekman, Klaas, W. J. F. van der Vijgh, & Jan B. Vermorken. (1999). Clinical and Preclinical Modulation of Chemotherapy-Induced Toxicity in Patients with Cancer. Drugs. 57(2). 133–155. 41 indexed citations
15.
Linn, Sabine C., Herbert M. Pinedo, J van Ark-Otte, et al.. (1997). Expression of drug resistance proteins in breast cancer, in relation to chemotherapy. International Journal of Cancer. 71(5). 787–795. 7 indexed citations
16.
Feller, N, Klaas Hoekman, Catharina M. Kuiper, et al.. (1997). A patient with adrenocortical carcinoma: characterization of its biological activity and drug resistance profile.. PubMed. 3(3). 389–94. 9 indexed citations
17.
18.
Hoekman, Klaas, et al.. (1996). Well-differentiated papillary mesothelioma of the peritoneum: A separate entity. European Journal of Cancer. 32(2). 255–258. 20 indexed citations
19.
Visser, J. & Klaas Hoekman. (1994). Arginine supplementation in the prevention and treatment of osteoporosis. Medical Hypotheses. 43(5). 339–342. 35 indexed citations
20.
Löwik, Clemens W.G.M., Gabri van der Pluijm, Klaas Hoekman, et al.. (1989). Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochemical and Biophysical Research Communications. 162(3). 1546–1552. 316 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giannoula Klement Breakdown of academic impact, for papers by Marek Z. Wojtukiewicz Breakdown of academic impact, for papers by K. Havemann Breakdown of academic impact, for papers by Vincent A. Memoli Breakdown of academic impact, for papers by Bridget A. Robinson Breakdown of academic impact, for papers by Cornelis F.M. Sier Breakdown of academic impact, for papers by Siow Ming Lee Breakdown of academic impact, for papers by Catherine Butterfield Breakdown of academic impact, for papers by Steven J. Harper Breakdown of academic impact, for papers by Jacintha O’Sullivan
Rankless by CCL
2026